Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 19 of 19 for “"Antileukemic activity"”.

  1. Enhancing The Antileukemic Activity Of The Bcl-2 Inhibitor, Venetoclax, Against Acute Myeloid Leukemia

    … need of novel strategies to enhance the anti-AML activity of VEN.In line with previous literature that has shown that the suppression of oxidative phosphorylation (OXPHOS) and/or mitochondrial function enhances the antileukemic activity of VEN, this dissertation tests two different drugs, CUDC-907 …

    wayne-thes Repository record for Enhancing The Antileukemic Activity Of The Bcl-2 Inhibitor, Venetoclax, Against Acute Myeloid Leukemia (opens in a new tab)

  2. Significance of frequencies, compositions and/or antileukemic activity of (DC-stimulated) invariant NKT, NK and CIK cells on the outcome of patients with AML, ALL and CLL

    … served as effector cells. Blast-lytic activity of iNKT, NK, CIK and T cells after MLC was examined using a cytotoxicity (fluorolysis) assay. The main results were: II.1) iNKT, NK and CIK cells increased after MLC independent of the applied ‘cocktail’ / ‘stimulator cell suspension’ …

    lmu-germany Repository record for Significance of frequencies, compositions and/or antileukemic activity of (DC-stimulated) invariant NKT, NK and CIK cells on the outcome of patients with AML, ALL and CLL (opens in a new tab)

  3. Επαγόμενα HLA-G+ T- ρυθμιστικά κύτταρα (iHLA-G+ Tregs) για τη θεραπεία της οξείας νόσου μοσχεύματος κατά ξενιστή (GVHD)

    … residual malignant cells. However, the alloreactivity of these same cells against recipient tissues can lead to graft-versus-host disease (GvHD), which remains one of the major complications of allo-HCT. Therefore, the development of therapeutic approaches that limit GvHD without compromising …

    greece Repository record for Επαγόμενα HLA-G+ T- ρυθμιστικά κύτταρα (iHLA-G+ Tregs) για τη θεραπεία της οξείας νόσου μοσχεύματος κατά ξενιστή (GVHD) (opens in a new tab)

  4. Synthetic studies on a model system for the spirobicyclic ring system of oscillatoxin D

    … natural product. Oscillatoxin D has shown some antileukemic activity and it might have undiscovered biological activity. It is a possible drug candidate.

    ttu Repository record for Synthetic studies on a model system for the spirobicyclic ring system of oscillatoxin D (opens in a new tab)

  5. Synthesis of fused and bridged ring systems

    … a compound that exhibits significant antileukemic activity. (2) A novel way of constructing bridged ring systems involving a reactive enone intermediate and 1,1,3-trisubstituted dienes has been effected. The unusual preference for the exo mode of cycloaddition is explained.</p>

    iastate Repository record for Synthesis of fused and bridged ring systems (opens in a new tab)

  6. Prädiktive Relevanz regulatorischer T-Zellsubpopulationen nach Stimulation mit dendritischen Zellen leukämischer Abstammung für die antileukämische T-Zellantwort

    … (GVHD), but also to impair antileukemic reactions. Aim: Since leukemia-derived dendritic-cells (DCleu) are known to improve antileukemic functionality of T-cells we evaluated the composition and development of distinct Treg-subtypes in AML-pts (n=12) compared to healthy …

    lmu-germany Repository record for Prädiktive Relevanz regulatorischer T-Zellsubpopulationen nach Stimulation mit dendritischen Zellen leukämischer Abstammung für die antileukämische T-Zellantwort (opens in a new tab)

  7. Development of Novel PBD-Based Antibody-Drug Conjugates Targeting CCRL2 and ICAM1 in TP53-Mutated High-Risk MDS/AML

    … targeting these molecules and evaluated their antileukemic activity. Both CCRL2- and ICAM1-targeting ADCs exhibited potent cytotoxicity in vitro, with anti-CCRL2 ADC demonstrating strong target specificity and superior efficacy in TP53-mutant MDS/AML models compared to CD33/CD123-directed ADCs …

    jhu Repository record for Development of Novel PBD-Based Antibody-Drug Conjugates Targeting CCRL2 and ICAM1 in TP53-Mutated High-Risk MDS/AML (opens in a new tab) Embargoed until 2030-05-01

  8. Synthetic studies related to the marine natural product oscillatoxin D

    … tropical marine bluegreen algae which possesses antileukemic activity. This dissertation describes progress towards the synthesis of structurally advanced intermediates for the total synthesis of osdllatoxin D. The overall goal of this research is to test synthetic methodology aimed at …

    ttu Repository record for Synthetic studies related to the marine natural product oscillatoxin D (opens in a new tab)

  9. Targeting Venetoclax Plus Azacitidine Resistance And Leukemia Stem Cells In Acute Myeloid Leukemia Via The Novel Imipridone Onc213

    … in our lab with known mitotoxic properties and antileukemic activity. ONC213 resensitizes VEN+AZA-R cells to VEN therapy in a dose dependent manner and the combination of ONC213+VEN demonstrates synergy and potent antileukemic activity against VEN+AZA-resistant and -sensitive cells and against …

    wayne-thes Repository record for Targeting Venetoclax Plus Azacitidine Resistance And Leukemia Stem Cells In Acute Myeloid Leukemia Via The Novel Imipridone Onc213 (opens in a new tab)

  10. Σχεδιασμός, σύνθεση και αποτίμηση βιολογικής δραστικότητας νέων στεροειδών εστέρων με τροποποιημένους αλκυλιωτικούς παράγοντες

    … specific DNA bases due to their high inherent reactivity, resulting in the non-specific alkylation of other cellular nucleophilic species such as amino acid residues or low molecular weight thiols. Several approaches have been explored to reduce the toxicity and increase the therapeutic efficacy …

    greece Repository record for Σχεδιασμός, σύνθεση και αποτίμηση βιολογικής δραστικότητας νέων στεροειδών εστέρων με τροποποιημένους αλκυλιωτικούς παράγοντες (opens in a new tab)

  11. Natural substrates and inhibitors of CYP1 family enzymes

    … agent (resveratrol) to a compound with antileukemic activity (picccatannol). Based on these findings interactions of CYP1 family enzymes with cancer preventative flavonoids, that have structure similar to resveratrol, were investigated. The flavonols quercetin, myricetin and kaempferol …

    greece Repository record for Natural substrates and inhibitors of CYP1 family enzymes (opens in a new tab)

  12. SINGLE-CHAIN VARIABLE FRAGMENT AFFINITY TUNING CAN OPTIMIZE ANTI-AML CAR-NK CELL FUNCTIONALTIY

    … Killer (NK) cells have powerful intrinsic antileukemic activity that can be redirected towards AML blasts with chimeric antigen receptor (CAR) engineering. Here, we study the functional consequence of CAR binding affinity on CAR-NK cell activation, cytolytic synapse formation, and …

    jhu Repository record for SINGLE-CHAIN VARIABLE FRAGMENT AFFINITY TUNING CAN OPTIMIZE ANTI-AML CAR-NK CELL FUNCTIONALTIY (opens in a new tab)

  13. Κυτταρογενετικές και βιοχημικές μελέτες αντικαρκινικών και εν δυνάμει αντικαρκινικών φαρμάκων

    … study, the cytogenetic and antineoplastic activity as well as the ability of apoptosis induction of 28 newly synthesized compounds were studied. These compounds were separated in two groups according to their chemical structure a) in 9 complex compounds of thiosemicarbazones with heavy …

    greece Repository record for Κυτταρογενετικές και βιοχημικές μελέτες αντικαρκινικών και εν δυνάμει αντικαρκινικών φαρμάκων (opens in a new tab)

  14. Scaffold optimisations of unnatural PPAP derivatives to increase the efficacy and specificity for medical applications

    … of new derivatives. Now a follow-up structure-activity relationship (SAR) study, aided by a novel C acylation strategy developed in the group, expanded the library with 25 new unnatural type B PPAPs. Antibiotic efficacies with minimum inhibitory concentrations (MICs) in the nanomolar range …

    qucosa-diss

  15. Antileukemic activities of human bone marrow and blood cells after culture in interleukins-2, -7 and -12

    … with allogeneic BMT due to an allogeneic antileukemic effect. Despite its benefits, the use of autologous BMT is limited by high relapse rates due to the persistence of leukemic stem cells in the autologous bone marrow (BM) and/or residual disease in the patient. Thus, it would be …

    ubc Repository record for Antileukemic activities of human bone marrow and blood cells after culture in interleukins-2, -7 and -12 (opens in a new tab) Download PDF for Antileukemic activities of human bone marrow and blood cells after culture in interleukins-2, -7 and -12 (opens in a new tab)

  16. Characterization and Reprogramming of T-cell Metabolic Dysfunction in Chronic Lymphocytic Leukemia for Improved Adoptive Cell Therapy

    … significantly improved the mitochondrial activity and metabolic fitness of CLL T cells. Moreover, idelalisib treatment remarkably shifted T-cell fate into central memory and less-differentiated subsets with reduced exhaustion signature. The established ex vivo treatment protocol enabled us …

    usf Repository record for Characterization and Reprogramming of T-cell Metabolic Dysfunction in Chronic Lymphocytic Leukemia for Improved Adoptive Cell Therapy (opens in a new tab)

  17. Clinical and predictive relevance of in vitro generation of dendritic cells of leukemic origin in patients with AML and MDS

    … These DCleu can elicit potent IEC-mediated antileukemic immune reactions ex vivo and presumably in vivo. This cumulative thesis includes three studies aimed at gaining deeper insights into the contribution of DC to antileukemic immune responses. In publication I (as co-author), the …

    lmu-germany Repository record for Clinical and predictive relevance of in vitro generation of dendritic cells of leukemic origin in patients with AML and MDS (opens in a new tab)